BioSpace News Archive

Medical Pendant Systems Market is driven by the growing need for these systems in intensive care units and operating theaters

The growing need for a safe and low-risk work space for the medical workforce is driving the global medical pendant systems market.

September 18, 2020
·
5 min read
Malignant Pleural Effusion Treatment Market is projected to expand at a healthy CAGR by 2025

A malignant pleural effusion refers to a health complication involving build-up of cancer cells containing fluid between the membranes lining the lungs.

September 18, 2020
·
5 min read
Gene Therapy Market Progress in Gene-editing and Genomics Tools to Stoke Demand of Gene Therapy

Introduction of new production, availability of reimbursement together with high occurrences of cancer are estimated to propel growth of the global gene therapy market in the years to come.

September 18, 2020
·
6 min read
Electric Tables Market for Physical Therapy, Examination and Operating: Therapy Area Specific Requirement to Open New Opportunities.

A rapidly emerging sector, the global electric tables market is buoyant with a large number of players finds a latest market research report by Transparency Market Research.

September 18, 2020
·
4 min read
Disinfectant Sprays Market | Several Players have been able to Gain Profit from Heightened Sales of Disinfectant Sprays

The use of disinfectant sprays is becoming a key part in managing in wide range of healthcare-associated infections in hospital and clinics settings.

September 18, 2020
·
3 min read
3D Laparoscopy Market: Increasing usage of the laparoscopic technique worldwide is anticipated to boost the market

Laparoscopy is a diagnostic procedure used to observe the abdominal section of a body.

September 18, 2020
·
5 min read
Deals

Vifor Pharma Group Announces Successful Sale of OM Pharma

Vifor Pharma has announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding Ltd.

September 18, 2020
·
3 min read
Genetown

Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO

160 patient balstilimab (PD-1) monotherapy trial achieves response rates of 14% in all treated patients and 19% in PD-L1 positive patients

September 18, 2020
·
3 min read
Pharm Country

Positive Pivotal Data for Libtayo® (cemiplimab) Monotherapy in Locally Advanced Basal Cell Carcinoma Featured as a Late-breaking Presentation at ESMO

Regeneron Pharmaceuticals, Inc. and Sanofi announced the presentation of positive results from the pivotal Phase 2 trial for the PD-1 inhibitor Libtayo® in patients with locally advanced basal cell carcinoma who had progressed on or were intolerant to hedgehog inhibitor therapy.

September 18, 2020
·
19 min read
Drug Development

Astellas and Seattle Genetics Announce PADCEV® (enfortumab vedotin-ejfv) Significantly Improved Overall Survival in Phase 3 Trial in Previously Treated Locally Advanced or Metastatic Urothelial Cancer

Astellas Pharma Inc. and Seattle Genetics, Inc. announced that a phase 3 trial of PADCEV® met its primary endpoint of overall survival compared to chemotherapy.

September 18, 2020
·
15 min read